Back
Spirax-Sarco Engineering PLC Vs. 4D Molecular Therapeutics Industry Stock Comparison
Sell
16
SPXSY
Spirax-Sarco Engineering PLC
Last Price:
57.20
Seasonality Move:
-1.73%
Sell
50
FDMT
4D Molecular Therapeutics
Last Price:
25.69
Seasonality Move:
-18.33%
Sell
16
Spirax-Sarco Engineering PLC (SPXSY)
is a Sell
Is Spirax-Sarco Engineering PLC a Buy, Sell or Hold?
- The current Spirax-Sarco Engineering PLC [SPXSY] share price is $57.20. The Score for SPXSY is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- SPXSY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
50
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
- The current 4D Molecular Therapeutics [FDMT] share price is $25.59. The Score for FDMT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- FDMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SPXSY Stock Price Chart
What is Spirax-Sarco Engineering PLC's stock price today?
-
The Spirax-Sarco Engineering PLC share price today is $57.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPXSY is experiencing slight buying pressure.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $25.59
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing selling pressure, which indicates risk of future bearish movement.
SPXSY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.65 | Sell |
| Relative Strength Index (14 RSI): | 18.23 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.95 - 60.43) | Sell |
| Bollinger Bands (100): | (60.26 - 67.38) | Sell |
FDMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.49 | Sell |
| Relative Strength Index (14 RSI): | 45.87 | Sell |
| Chaikin Money Flow: | -232231 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.49 - 27.33) | Sell |
| Bollinger Bands (100): | (20.27 - 30.09) | Buy |
SPXSY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.2 | Sell |
| 20-day SMA: | 58.07 | Sell |
| 50-day SMA: | 63 | Sell |
| 200-day SMA: | 61.92 | Sell |
| 8-day EMA: | 57.31 | Sell |
| 20-day EMA: | 58.55 | Sell |
| 50-day EMA: | 61.12 | Sell |
| 200-day EMA: | 63.05 | Sell |
FDMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.94 | Sell |
| 20-day SMA: | 25.44 | Buy |
| 50-day SMA: | 28.17 | Sell |
| 200-day SMA: | 19.52 | Buy |
| 8-day EMA: | 25.9 | Sell |
| 20-day EMA: | 26.08 | Sell |
| 50-day EMA: | 26.47 | Sell |
| 200-day EMA: | 21.88 | Buy |
Spirax-Sarco Engineering PLC Earnings Growth & SPXSY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.32 per share.
Spirax-Sarco Engineering PLC Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
4D Molecular Therapeutics Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||